MELARSOPROL, 36mg/ml, 5ml, amp.
STD
DINJMELA3A5
Valid Article
Account code:
60000
HS Code:
{}
Last Updated on:
12/04/2024, 17:56:55
Former
Code(s):
DINJMELA3A-
6.5.5.1 - African trypanosomiasis
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01CD01
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
MELARSOPROL
Therapeutic Action
Antitrypanosomal (arsenic derivative)
Indications
Meningoencephalitic stage of African trypanosomiasis due to T. b. gambiense and T. b. rhodesiense
- See WHO interim guidelines for the treatment of gambiense human African trypanosomiasis, 2019
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
Must be given as slow IV injection.
Never administer by IM or SC route.
Precautions for Use
Due to the high toxicity and numerous adverse effects, patients must be treated in hospital settings, under close medical supervision.
Propyleneglycol (melarsoprol solvent) corrodes plastic. Single-use syringes should therefore be prepared just before giving injections.
Contraindicated during pregnancy.
Storage
- Below 25°C - Protect from sunlight
- Dangerous product whose stock must be properly managed.